Kurk Functional Foods
Overview
We have created the most effective alternative to Ibuprofen, from 100% plants.
Founded by two cancer survivors (and best friends) Dr Harrison Weisinger and Trent Scanlen, we are vertically integrated and are well positioned to scale rapidly into two huge markets worldwide - Herbal medicine ($550B) and Functional Foods ($309B).
After 4 years of R&D in our purpose built lab in Twickenham, we have cleanly distilled curcumin into a micellar emulsion and combined it with other functional plant extracts to create a delicious drink in 3 flavours.
We have achieved over £3.5m in online sales and have pioneered incredible scientific and medical results. We now want to scale our KURK brand, enter retail and unlock distribution partnerships.
Company Highlights
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volut
Open an account to get
access to more details
Problem and Solution
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque. Donec tincidunt, dolor luctus lobortis ultrices,
Open an account to get
access to more details
Competitive Advantage
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volutpat ante eget tincidunt feugiat. Nunc placerat sapien et
Open an account to get
access to more details
Current Shareholders & Investors
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque.
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
BetterX
BetterX offers B2B and B2B2C white-label and API driven software solutions to traditional institutions to offer digital asset services to their clients.
Paycepaid
Paycepaid is a Software as a Service debt collection solution unlike any on the market today with a heavy focus on the debtor. Empowering businesses to manage their end to end collections while providing debtors with a magnitude of options to reduce financial stress and anxiety.
Wholesale Investor
Wholesale Investor, with over 45,000 subscribers, is a leading private capital marketplace operating across Australia, Singapore, and the UK. It has a 15-year track record of connecting private market opportunities with HNW, professional, and family office investors. In just 4 years, our product...
PRIMAL ORGANIX
Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.
Sustainable Fintech Fund
Startupbootcamp, the #1 Accelerator in the world outside of the US, established in 2010, operates in 27 countries around the globe, has accelerated over 1600+ startups with a success rate of 76% remaining active, raised over $2.2B in total funding, a network of more than 300+ investors, 5000...
Misio
Sustainability performance and stakeholder communications are now fundamental to overall corporate profitability and impact. Misio simplifies a complex eco-system to help large & listed companies shift the sustainability narrative out from annual reports into easy to understand digital...
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
National Property Group
National Property Group (NPG) is a trusted alternative provider of property data and insights empowering informed decisions for all property market participants. NPG relaunched its property data & analytics intelligence platform in 2021, delivering instant insights from more than 40 years of...
Novapep
Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be as effective as expensive, injectable biologic drugs (a...
Backed By Leading Investment Groups and Family Offices
